2 Matching Annotations
  1. Aug 2020
  2. biorxiv.org biorxiv.org
    http://biorxiv.org/cgi/content/short/2020.08.05.238394
    1
    1. ErikStuchly 20 Aug 2020

      Luban, J., Sattler, R., Mühlberger, E., Graci, J. D., Cao, L., Weetall, M., Trotta, C., Colacino, J. M., Bavari, S., Strambio-De-Castillia, C., Suder, E. L., Wang, Y., Soloveva, V., Cintron-Lue, K., Naryshkin, N. A., Pykett, M., Welch, E. M., O’Keefe, K., Kong, R., … Peltz, S. (2020). The DHODH Inhibitor PTC299 Arrests SARS-CoV-2 Replication and Suppresses Induction of Inflammatory Cytokines. BioRxiv, 2020.08.05.238394. https://doi.org/10.1101/2020.08.05.238394

      is:preprint lang:en COVID-19 inflammatory cytokine suppression inflammation intervention inhibition blocked replication safety pharmacokinetics drug therapy selectivity
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/cgi/content/short/2020.08.05.238394
  3. Jul 2020
  4. www.newscientist.com www.newscientist.com
    Which covid-19 treatments work and how close are we to getting more?
    1
    1. Danaeioak 31 Jul 2020

      Vaughan, A. (n.d.). Which covid-19 treatments work and how close are we to getting more? New Scientist. Retrieved 31 July 2020, from https://www.newscientist.com/article/2250176-which-covid-19-treatments-work-and-how-close-are-we-to-getting-more/

      is:webpage lang:en COVID-19 treatment dexamethanose RECOVERY trial remdesivir Solidarity trial mixed results anti-inflammatory tocilizumab interferon beta blood plasma antibodies drug replication inhibition virus destruction
    Visit annotations in context

    Tags

    Annotators

    URL

    newscientist.com/article/2250176-which-covid-19-treatments-work-and-how-close-are-we-to-getting-more/